ReP USP - Resultado da busca

Artigo de periodico
Immunomodulatory protective effects of Rb9 cyclic-peptide in a metastatic melanoma setting and the involvement of dendritic cells (2020)
Machado, Fabrício Castro; Girola, Natália; Maia, Vera Susana Carneiro; Santos, Patricia Cruz Bergami; Morais, Alice Santana ; Azevedo, Ricardo Alexandre ; Figueiredo, Carlos Rogerio de ; Barbuto, José Alexandre Marzagão ; Travassos, Luiz Rodolpho Raja Gabaglia
Source: Frontiers in Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, CÉLULAS DENDRÍTICAS, PROLIFERAÇÃO CELULAR, MACRÓFAGOS, LINFÓCITOS, MELANOMA, ADJUVANTES IMUNOLÓGICOS, METÁSTASE ANIMAL, CAMUNDONGOS, PEPTÍDEOS CÍCLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Fabrício Castro et al. Immunomodulatory protective effects of Rb9 cyclic-peptide in a metastatic melanoma setting and the involvement of dendritic cells. Frontiers in Immunology, v. 10, p. 20 , 2020Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2019.03122. Acesso em: 06 nov. 2024.
APA
Machado, F. C., Girola, N., Maia, V. S. C., Santos, P. C. B., Morais, A. S., Azevedo, R. A., et al. (2020). Immunomodulatory protective effects of Rb9 cyclic-peptide in a metastatic melanoma setting and the involvement of dendritic cells. Frontiers in Immunology, 10, 20 . doi:10.3389/fimmu.2019.03122
NLM
Machado FC, Girola N, Maia VSC, Santos PCB, Morais AS, Azevedo RA, Figueiredo CR de, Barbuto JAM, Travassos LRRG. Immunomodulatory protective effects of Rb9 cyclic-peptide in a metastatic melanoma setting and the involvement of dendritic cells [Internet]. Frontiers in Immunology. 2020 ; 10 20 .[citado 2024 nov. 06 ] Available from: https://doi.org/10.3389/fimmu.2019.03122
Vancouver
Machado FC, Girola N, Maia VSC, Santos PCB, Morais AS, Azevedo RA, Figueiredo CR de, Barbuto JAM, Travassos LRRG. Immunomodulatory protective effects of Rb9 cyclic-peptide in a metastatic melanoma setting and the involvement of dendritic cells [Internet]. Frontiers in Immunology. 2020 ; 10 20 .[citado 2024 nov. 06 ] Available from: https://doi.org/10.3389/fimmu.2019.03122
Artigo de periodico
Tolerogenic IDO(+) dendritic cells are induced by PD-1-expressing mast cells (2016)
Rodrigues, Cecilia Pessoa; Ferreira, Ana Carolina Franco; Pinho, Mariana Pereira; Moraes, Cristiano Jacob de; Bergami-Santos, Patricia Cruz; Barbuto, José Alexandre Marzagão
Source: Frontiers in Immunology. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Cecilia Pessoa et al. Tolerogenic IDO(+) dendritic cells are induced by PD-1-expressing mast cells. Frontiers in Immunology, v. 7, n. 9, p. 1-17, 2016Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2016.00009. Acesso em: 06 nov. 2024.
APA
Rodrigues, C. P., Ferreira, A. C. F., Pinho, M. P., Moraes, C. J. de, Bergami-Santos, P. C., & Barbuto, J. A. M. (2016). Tolerogenic IDO(+) dendritic cells are induced by PD-1-expressing mast cells. Frontiers in Immunology, 7( 9), 1-17. doi:10.3389/fimmu.2016.00009
NLM
Rodrigues CP, Ferreira ACF, Pinho MP, Moraes CJ de, Bergami-Santos PC, Barbuto JAM. Tolerogenic IDO(+) dendritic cells are induced by PD-1-expressing mast cells [Internet]. Frontiers in Immunology. 2016 ; 7( 9): 1-17.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3389/fimmu.2016.00009
Vancouver
Rodrigues CP, Ferreira ACF, Pinho MP, Moraes CJ de, Bergami-Santos PC, Barbuto JAM. Tolerogenic IDO(+) dendritic cells are induced by PD-1-expressing mast cells [Internet]. Frontiers in Immunology. 2016 ; 7( 9): 1-17.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3389/fimmu.2016.00009
Artigo de periodico
Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets (2015)
Romagnoli, Graziela Gorete; Zelante, Bruna Barbosa; Toniolo, Patricia Argenta; Migliori, Isabella Katz; Barbuto, José Alexandre Marzagão
Source: Frontiers in Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, CÉLULAS DENDRÍTICAS, CELULAS CULTIVADAS DE TUMOR, IMUNOTERAPIA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROMAGNOLI, Graziela Gorete et al. Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets. Frontiers in Immunology, v. 5, p. 1-5, 2015Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2014.00692. Acesso em: 06 nov. 2024.
APA
Romagnoli, G. G., Zelante, B. B., Toniolo, P. A., Migliori, I. K., & Barbuto, J. A. M. (2015). Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets. Frontiers in Immunology, 5, 1-5. doi:10.3389/fimmu.2014.00692
NLM
Romagnoli GG, Zelante BB, Toniolo PA, Migliori IK, Barbuto JAM. Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets [Internet]. Frontiers in Immunology. 2015 ; 5 1-5.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3389/fimmu.2014.00692
Vancouver
Romagnoli GG, Zelante BB, Toniolo PA, Migliori IK, Barbuto JAM. Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets [Internet]. Frontiers in Immunology. 2015 ; 5 1-5.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3389/fimmu.2014.00692

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em